Literature DB >> 15100935

Improvement of apraxia of lid opening by STN-stimulation in a 70-year-old patient with Parkinson's disease. A case report.

G Fuss1, J Spiegel, T Magnus, J R Moringlane, G Becker, U Dillmann.   

Abstract

We report on a 70-year-old female patient with Parkinson's disease, who showed an improvement of a preexisting apraxia of lid opening on electrical impulses, so-called deep brain stimulation (DBS) delivered to the subthalamic nucleus (STN). This was not described by any other authors before. Up to now, the appearance of apraxia of lid opening was observed only as a side effect after deep brain stimulation in the nucleus subthalamicus. We suggest that these differences may be due to the region of the nucleus subthalamicus that is influenced by the stimulation.

Entities:  

Mesh:

Year:  2004        PMID: 15100935     DOI: 10.1055/s-2003-812466

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  4 in total

1.  Effects of varying subthalamic nucleus stimulation on apraxia of lid opening in Parkinson's disease.

Authors:  Giorgio Tommasi; Paul Krack; Valérie Fraix; Pierre Pollak
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

2.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

3.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

Review 4.  Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.

Authors:  Ali G Hamedani; Daniel R Gold
Journal:  Front Neurol       Date:  2017-07-18       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.